ProPhase Labs (NASDAQ: PRPH) reported Q1 EPS of ($0.13), $0.05 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $1.43 million versus the consensus estimate of $2.45 million.

For earnings history and earnings-related data on ProPhase Labs (PRPH) click here.